HealthEquity (NASDAQ:HQY) Hits New 12-Month High at $73.51

HealthEquity, Inc. (NASDAQ:HQYGet Rating) reached a new 52-week high during trading on Wednesday . The company traded as high as $73.51 and last traded at $73.48, with a volume of 24479 shares changing hands. The stock had previously closed at $71.14.

Analyst Ratings Changes

HQY has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft increased their target price on shares of HealthEquity from $67.00 to $68.00 and gave the company a “buy” rating in a research report on Thursday, September 8th. KeyCorp assumed coverage on shares of HealthEquity in a research report on Thursday, September 15th. They set an “overweight” rating and a $85.00 price objective on the stock. SVB Leerink raised their price objective on shares of HealthEquity from $67.00 to $76.00 and gave the stock an “outperform” rating in a research report on Tuesday, June 7th. Raymond James raised their price objective on shares of HealthEquity from $70.00 to $75.00 and gave the stock an “outperform” rating in a research report on Monday, September 12th. Finally, Barrington Research raised their price objective on shares of HealthEquity from $70.00 to $75.00 in a research report on Tuesday, June 7th. Two analysts have rated the stock with a sell rating, one has issued a hold rating and eleven have issued a buy rating to the company. According to data from MarketBeat.com, HealthEquity currently has an average rating of “Moderate Buy” and an average target price of $75.36.

HealthEquity Trading Up 2.3 %

The business’s 50-day simple moving average is $63.03 and its 200-day simple moving average is $62.79.

HealthEquity (NASDAQ:HQYGet Rating) last announced its earnings results on Tuesday, September 6th. The company reported $0.33 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.33. HealthEquity had a negative net margin of 7.82% and a positive return on equity of 2.86%. During the same quarter in the previous year, the company earned $0.21 earnings per share. Equities analysts expect that HealthEquity, Inc. will post 0.69 EPS for the current year.

Insider Transactions at HealthEquity

In related news, COO Edward Bloomberg sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, August 1st. The shares were sold at an average price of $57.63, for a total value of $57,630.00. Following the completion of the sale, the chief operating officer now directly owns 59,850 shares in the company, valued at $3,449,155.50. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In other HealthEquity news, COO Edward Bloomberg sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, August 1st. The shares were sold at an average price of $57.63, for a total transaction of $57,630.00. Following the completion of the sale, the chief operating officer now directly owns 59,850 shares in the company, valued at $3,449,155.50. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Ian Sacks sold 25,000 shares of the business’s stock in a transaction on Tuesday, September 20th. The stock was sold at an average price of $72.28, for a total transaction of $1,807,000.00. Following the transaction, the director now directly owns 126,570 shares in the company, valued at $9,148,479.60. The disclosure for this sale can be found here. Insiders own 2.80% of the company’s stock.

Hedge Funds Weigh In On HealthEquity

Several institutional investors have recently modified their holdings of HQY. Dimensional Fund Advisors LP grew its position in HealthEquity by 5.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 539,889 shares of the company’s stock valued at $23,884,000 after buying an additional 27,146 shares in the last quarter. BNP Paribas Arbitrage SA lifted its position in shares of HealthEquity by 107.9% in the fourth quarter. BNP Paribas Arbitrage SA now owns 24,654 shares of the company’s stock worth $1,091,000 after purchasing an additional 12,798 shares in the last quarter. Citigroup Inc. increased its holdings in HealthEquity by 69.5% in the fourth quarter. Citigroup Inc. now owns 27,089 shares of the company’s stock worth $1,198,000 after buying an additional 11,108 shares during the last quarter. Qube Research & Technologies Ltd acquired a new position in HealthEquity during the fourth quarter valued at approximately $474,000. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of HealthEquity by 2.1% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 814,194 shares of the company’s stock valued at $36,020,000 after acquiring an additional 16,431 shares during the period. Institutional investors own 99.43% of the company’s stock.

About HealthEquity

(Get Rating)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Recommended Stories

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.